Literature DB >> 20026527

The proper role of evidence in complementary/alternative medicine.

Kirsten Hansen1, Klemens Kappel.   

Abstract

In this article we explore the role evidence ought to play in complementary and alternative medicine (CAM). First, we consider the claim that evidence in the form of randomized controlled trials (RCTs) cannot be obtained for CAMs. Second, we consider various claims to the effect that there are ways of obtaining evidence that do not make use of RCTs. We argue that there is no good reason why CAM should be exempted from the general requirement that treatments undergo evaluation by RCT. Third, we consider two implications for health care policy. First, many activities in conventional medicine have never been rigorously evaluated and are widely in use nonetheless. We argue that this fails to provide a reason for exempting CAM from a demand for evidence. Second, CAM use may be compared to a choice of lifestyle, and this has a significant impact on which requirements of evidence can reasonably be imposed.

Mesh:

Year:  2009        PMID: 20026527     DOI: 10.1093/jmp/jhp059

Source DB:  PubMed          Journal:  J Med Philos        ISSN: 0360-5310


  4 in total

1.  Plausibility and evidence: the case of homeopathy.

Authors:  Lex Rutten; Robert T Mathie; Peter Fisher; Maria Goossens; Michel van Wassenhoven
Journal:  Med Health Care Philos       Date:  2013-08

2.  Pre-trial beliefs in complementary and alternative medicine: whose pre-trial belief should be considered?

Authors:  Kirsten Hansen; Klemens Kappel
Journal:  Med Health Care Philos       Date:  2012-02

Review 3.  Life issues in multiple sclerosis.

Authors:  Rex D Simmons
Journal:  Nat Rev Neurol       Date:  2010-09-21       Impact factor: 42.937

Review 4.  Reiki and related therapies in the dialysis ward: an evidence-based and ethical discussion to debate if these complementary and alternative medicines are welcomed or banned.

Authors:  Martina Ferraresi; Roberta Clari; Irene Moro; Elena Banino; Enrico Boero; Alessandro Crosio; Romina Dayne; Lorenzo Rosset; Andrea Scarpa; Enrica Serra; Alessandra Surace; Alessio Testore; Nicoletta Colombi; Barbara Giorgina Piccoli
Journal:  BMC Nephrol       Date:  2013-06-21       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.